| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
  free 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
  free 
  free 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 Neuroprotective effects of curcumin Cole GM; Teter B; Frautschy SAAdv Exp Med Biol  2007[]; 595 (ä): 197-212Neurodegenerative diseases result in the loss of functional neurons and synapses.  Although future stem cell therapies offer some hope, current treatments for most  of these diseases are less than adequate and ourbest hope is to prevent these  devastating diseases. Neuroprotective approaches work best prior to the  initiation of damage, suggesting that some safe and effective prophylaxis would  be highly desirable. Curcumin has an outstanding safety profile and a number of  pleiotropic actions with potential for neuroprotective efficacy, including  anti-inflammatory, antioxidant, and anti-protein-aggregate activities. These can  be achieved at submicromolar levels. Curcumin's dose-response curves are strongly  dose dependent and often biphasic so that in vitro data need to be cautiously  interpreted; many effects might not be achievable in target tissues in vivo with  oral dosing. However, despite concerns about poor oral bioavailability, curcumin  has at least 10 known neuroprotective actions and many of these might be realized  in vivo. Indeed, accumulating cell culture and animal model data show that  dietary curcumin is a strong candidate for use in the prevention or treatment of  major disabling age-related neurodegenerative diseases like Alzheimer's,  Parkinson's, and stroke. Promising results have already led to ongoing pilot  clinical trials.|Animals[MESH]|Curcumin/*pharmacology/therapeutic use[MESH]|Dose-Response Relationship, Drug[MESH]|Humans[MESH]|Neuroprotective Agents/*pharmacology/therapeutic use[MESH]
 |